5-Amino-1MQ: A Comprehensive Guide to This Emerging Metabolic Compound
5-Amino-1MQ (5-amino-1-methylquinolinium) is a small-molecule NNMT inhibitor peptide-category compound that works by blocking nicotinamide N-methyltransferase, an enzyme that depletes NAD+ and slows cellular energy production, particularly in people with obesity or metabolic dysfunction. Despite being grouped with peptide therapeutics in many research and wellness contexts, it is technically not a peptide; it is a quinolinium derivative first characterized in 2017. This guide covers what 5-Amino-1MQ does, how it works, what the animal research shows, how it is used in practice, its safety profile, and where the evidence currently stands.
5-Amino-1MQ
27 min read
